Gene · 148
Papers1,657
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 1,657
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The Selective α1 Antagonist Tamsulosin Alters ECM Distributions and Cellular Metabolic Functions of ARPE 19 Cells in a Concentration-Dependent Manner. | Bioengineering (Basel) | 2022 | 36290524 | PubTator, text mining | PubMed |
| Myocardial TRPC6-mediated Zn2+ influx induces beneficial positive inotropy through β-adrenoceptors. | Nat Commun | 2022 | 36289215 | PubTator, text mining | PubMed |
| Heterogeneous network propagation with forward similarity integration to enhance drug-target association prediction. | PeerJ Comput Sci | 2022 | 36262151 | PubTator, text mining | PubMed |
| Network pharmacology study on the potential effect mechanism of Chuanzhi Tongluo Capsule in the treatment of cerebral infarction. | Medicine (Baltimore) | 2022 | 36254030 | PubTator, text mining | PubMed |
| The Mechanism of Crocetin Targeting Cardiovascular Disease Based on Network Pharmacology Constrained by Spectral Experiments. | Chem Biodivers | 2022 | 36251941 | PubTator, text mining | PubMed |
| Network Pharmacology-Based Analysis of the Potential Biological Mechanisms of Coix Seed against Colorectal Cancer. | Evid Based Complement Alternat Med | 2022 | 36248436 | PubTator, text mining | PubMed |
| FAM171B as a Novel Biomarker Mediates Tissue Immune Microenvironment in Pulmonary Arterial Hypertension. | Mediators Inflamm | 2022 | 36248192 | PubTator, text mining | PubMed |
| Aberrant lncRNA-mRNA expression profile and function networks during the adipogenesis of mesenchymal stem cells from patients with ankylosing spondylitis. | Front Genet | 2022 | 36246583 | PubTator, text mining | PubMed |
| Dysregulated autoantibodies targeting vaso- and immunoregulatory receptors in Post COVID Syndrome correlate with symptom severity. | Front Immunol | 2022 | 36238301 | PubTator, text mining | PubMed |
| Discovery of a Potent and Highly Selective Dipeptidyl Peptidase IV and Carbonic Anhydrase Inhibitor as "Antidiabesity" Agents Based on Repurposing and Morphing of WB-4101. | J Med Chem | 2022 | 36201615 | PubTator, text mining | PubMed |
| Systems Network Pharmacology-Based Prediction and Analysis of Potential Targets and Pharmacological Mechanism of Actinidia chinensis Planch. Root Extract for Application in Hepatocellular Carcinoma. | Evid Based Complement Alternat Med | 2022 | 36193154 | PubTator, text mining | PubMed |
| Mechanism of tonifying-kidney Chinese herbal medicine in the treatment of chronic heart failure. | Front Cardiovasc Med | 2022 | 36172573 | PubTator, text mining | PubMed |
| Integrative Analyses Identify KCNJ15 as a Candidate Gene in Patients with Epilepsy. | Neurol Ther | 2022 | 36168094 | PubTator, text mining | PubMed |
| Multitargeting nature of muscarinic orthosteric agonists and antagonists. | Front Physiol | 2022 | 36148314 | PubTator, text mining | PubMed |
| m7G regulator-mediated molecular subtypes and tumor microenvironment in kidney renal clear cell carcinoma. | Front Pharmacol | 2022 | 36147333 | PubTator, text mining | PubMed |
| Psychostimulants Modafinil, Atomoxetine and Guanfacine Impair Bone Cell Differentiation and MSC Migration. | Int J Mol Sci | 2022 | 36142172 | PubTator, text mining | PubMed |
| Vasovagal Syncope Is Associated with Variants in Genes Involved in Neurohumoral Signaling Pathways. | Genes (Basel) | 2022 | 36140820 | PubTator, text mining | PubMed |
| GPCR heteromers: An overview of their classification, function and physiological relevance. | Front Endocrinol (Lausanne) | 2022 | 36111299 | PubTator, text mining | PubMed |
| Risk of intraoperative floppy iris syndrome among selective alpha-1 blockers-A consistency model of 6,488 cases. | Front Med (Lausanne) | 2022 | 36111121 | PubTator, text mining | PubMed |
| Role of the CCL2-CCR2 axis in cardiovascular disease: Pathogenesis and clinical implications. | Front Immunol | 2022 | 36110847 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/148/papers?page=9